GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TiumBio Co Ltd (XKRX:321550) » Definitions » EV-to-FCF

TiumBio Co (XKRX:321550) EV-to-FCF : -4.34 (As of Apr. 26, 2024)


View and export this data going back to 2019. Start your Free Trial

What is TiumBio Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, TiumBio Co's Enterprise Value is ₩169,350 Mil. TiumBio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-38,977 Mil. Therefore, TiumBio Co's EV-to-FCF for today is -4.34.

The historical rank and industry rank for TiumBio Co's EV-to-FCF or its related term are showing as below:

XKRX:321550' s EV-to-FCF Range Over the Past 10 Years
Min: -178.54   Med: -10.52   Max: -3
Current: -3.85

During the past 7 years, the highest EV-to-FCF of TiumBio Co was -3.00. The lowest was -178.54. And the median was -10.52.

XKRX:321550's EV-to-FCF is ranked worse than
100% of 392 companies
in the Biotechnology industry
Industry Median: 4.3 vs XKRX:321550: -3.85

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-26), TiumBio Co's stock price is ₩7280.00. TiumBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-734.000. Therefore, TiumBio Co's PE Ratio for today is At Loss.


TiumBio Co EV-to-FCF Historical Data

The historical data trend for TiumBio Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TiumBio Co EV-to-FCF Chart

TiumBio Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial -64.77 -42.29 -12.10 -10.71 -5.93

TiumBio Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.71 -8.70 -9.07 -4.22 -5.93

Competitive Comparison of TiumBio Co's EV-to-FCF

For the Biotechnology subindustry, TiumBio Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TiumBio Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TiumBio Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where TiumBio Co's EV-to-FCF falls into.



TiumBio Co EV-to-FCF Calculation

TiumBio Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=169349.940/-38977.179
=-4.34

TiumBio Co's current Enterprise Value is ₩169,350 Mil.
TiumBio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-38,977 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TiumBio Co  (XKRX:321550) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

TiumBio Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7280.00/-734.000
=At Loss

TiumBio Co's share price for today is ₩7280.00.
TiumBio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-734.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


TiumBio Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of TiumBio Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


TiumBio Co (XKRX:321550) Business Description

Traded in Other Exchanges
N/A
Address
49, Daewangpangyo-ro 644beon-gil, Bundang-gu, 4th floor, Gyeonggi, Seongnam, KOR, 13493
TiumBio Co Ltd is a Biopharmaceutical company. It is engaged in research and development of rare and intractable diseases. The company's products are in pipeline. It offers products such as Idiopathic pulmonary fibrosis therapies, immune chemotherapy, endometriosis therapies, hemophilia.

TiumBio Co (XKRX:321550) Headlines

No Headlines